Stock comparison
Side-by-side financials for CLGN and ZBH. Compare market value, revenue, profit, margins, filings, and source pages in one place.
Quick answer
ZBH is larger
Market cap data is available for the leading company in this comparison.
Market value leader
ZBH
Latest market capitalization comparison.
Revenue leader
ZBH
CLGN: $2.37M vs ZBH: $8.23B.
Profit leader
ZBH
CLGN: -$11.49M vs ZBH: $705.10M.
Margin leader
ZBH
CLGN: -484.6% vs ZBH: 8.6% net margin.
| Metric | CLGN | ZBH |
|---|---|---|
| Market cap | - | $17.26 B |
| US-listed rank | - | #675 |
| Revenue (latest FY) | $2.37M | $8.23B |
| Net income (latest FY) | -$11.49M | $705.10M |
| Net margin | -484.6% | 8.6% |
| P/E (trailing FY) | - | 24.5x |
| SEC filings | 317 | 1,000 |
Jump from this comparison into the underlying pages for market value, annual fundamentals, and company filing history.
Market cap uses refreshed market data. Revenue, net income, margins, and trailing fiscal-year P/E use annual company facts from filings. If a metric is missing, the source data did not have a clean recent annual value for that company.
In their latest fiscal years, CollPlant Biotechnologies Ltd reported $2.37M in revenue while ZIMMER BIOMET HOLDINGS, INC. reported $8.23B.
Full pages: CollPlant Biotechnologies Ltd and ZIMMER BIOMET HOLDINGS, INC., or browse the full rankings.